|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Humeau M, Vignolle-Vidoni A, Sicard F,
Martins F, Bournet B, Buscail L, Torrisani J and Cordelier P:
Salivary MicroRNA in pancreatic cancer patients. PLoS One.
10:e01309962015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Subramani R, Gangwani L, Nandy SB,
Arumugam A, Chattopadhyay M and Lakshmanaswamy R: Emerging roles of
microRNAs in pancreatic cancer diagnosis, therapy and prognosis
(Review). Int J Oncol. 47:1203–1210. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fuchs CS, Colditz GA, Stampfer MJ,
Giovannucci EL, Hunter DJ, Rimm EB, Willett WC and Speizer FE: A
prospective study of cigarette smoking and the risk of pancreatic
cancer. Arch Intern Med. 156:2255–2260. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gapstur SM, Gann PH, Lowe W, Liu K,
Colangelo L and Dyer A: Abnormal glucose metabolism and pancreatic
cancer mortality. JAMA. 283:2552–2558. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Michaud DS, Giovannucci E, Willett WC,
Colditz GA, Stampfer MJ and Fuchs CS: Physical activity, obesity,
height, and the risk of pancreatic cancer. JAMA. 286:921–929. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
He D, Miao H, Xu Y, Xiong L, Wang Y, Xiang
H, Zhang H and Zhang Z: MiR-371-5p facilitates pancreatic cancer
cell proliferation and decreases patient survival. PLoS One.
9:e1129302014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wagner M, Redaelli C, Lietz M, Seiler CA,
Friess H and Büchler MW: Curative resection is the single most
important factor determining outcome in patients with pancreatic
adenocarcinoma. Br J Surg. 91:586–594. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stathis A and Moore MJ: Advanced
pancreatic carcinoma: Current treatment and future challenges. Nat
Rev Clin Oncol. 7:163–172. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: The impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Boudreau RL, Jiang P, Gilmore BL, et al:
Transcriptome-wide discovery of microRNA binding sites in human
brain. Neuron. 81:294–305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao L, Chen X and Cao Y: New role of
microRNA: Carcinogenesis and clinical application in cancer. Acta
Biochim Biophys Sin (Shanghai). 43:831–839. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hagan JP and Croce CM: MicroRNAs in
carcinogenesis. Cytogenet Genome Res. 118:252–259. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ganci F, Vico C, Korita E, Sacconi A,
Gallo E, Mori F, Cambria A, Russo E, Anile M, Vitolo D, et al:
MicroRNA expression profiling of thymic epithelial tumors. Lung
Cancer. 85:197–204. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Thorns C, Schurmann C, Gebauer N, et al:
Global microRNA profiling of pancreatic neuroendocrine neoplasias.
Anticancer Res. 34:2249–2254. 2014.PubMed/NCBI
|
|
19
|
Devor EJ, Hovey AM, Goodheart MJ,
Ramachandran S and Leslie KK: microRNA expression profiling of
endometrial endometrioid adenocarcinomas and serous adenocarcinomas
reveals profiles containing shared, unique and differentiating
groups of microRNAs. Oncol Rep. 26:995–1002. 2011.PubMed/NCBI
|
|
20
|
Fabbri M, Ivan M, Cimmino A, Negrini M and
Calin GA: Regulatory mechanisms of microRNAs involvement in cancer.
Expert Opin Biol Ther. 7:1009–1019. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu H, Xu XF, Zhao Y, Tang MC, Zhou YQ, Lu
J and Gao FH: MicroRNA-191 promotes pancreatic cancer progression
by targeting USP10. Tumour Biol. 35:12157–12163. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu Z, Xu Y, Du J, Tan J and Jiao H:
Expression of microRNA-218 in human pancreatic ductal
adenocarcinoma and its correlation with tumor progression and
patient survival. J Surg Oncol. 109:89–94. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao C, Zhang J, Zhang S, Yu D, Chen Y,
Liu Q, Shi M, Ni C and Zhu M: Diagnostic and biological
significance of microRNA-192 in pancreatic ductal adenocarcinoma.
Oncol Rep. 30:276–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sadakari Y, Ohtsuka T, Ohuchida K,
Tsutsumi K, Takahata S, Nakamura M, Mizumoto K and Tanaka M:
MicroRNA expression analyses in preoperative pancreatic juice
samples of pancreatic ductal adenocarcinoma. JOP. 11:587–592.
2010.PubMed/NCBI
|
|
27
|
Shao JY, Huang XM, Yu XJ, Huang LX, Wu QL,
Xia JC, Wang HY, Feng QS, Ren ZF, Ernberg I, et al: Loss of
heterozygosity and its correlation with clinical outcome and
Epstein-Barr virus infection in nasopharyngeal carcinoma.
Anticancer Res. 21:3021–3029. 2001.PubMed/NCBI
|
|
28
|
Wang Y, Xu P, Yao J, Yang R, Shi Z, Zhu X,
Feng X and Gao S: MicroRNA-216b is down-regulated in human gastric
adenocarcinoma and inhibits proliferation and cell cycle
progression by targeting oncogene HDAC8. Target Oncol. 11:197–207.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu FY, Zhou SJ, Deng YL, Zhang ZY, Zhang
EL, Wu ZB, Huang ZY and Chen XP: MiR-216b is involved in
pathogenesis and progression of hepatocellular carcinoma through
HBx-miR-216b-IGF2BP2 signaling pathway. Cell Death Dis.
6:e16702015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zheng L, Zhang X, Yang F, Zhu J, Zhou P,
Yu F, Hou L, Xiao L, He Q and Wang B: Regulation of the P2×7R by
microRNA-216b in human breast cancer. Biochem Biophys Res Commun.
452:197–204. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim SY, Lee YH and Bae YS: MiR-186,
miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular
senescence by targeting α subunit of protein kinase CKII in human
colorectal cancer cells. Biochem Biophys Res Commun. 429:173–179.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Deng M, Tang H, Zhou Y, Zhou M, Xiong W,
Zheng Y, Ye Q, Zeng X, Liao Q, Guo X, et al: miR-216b suppresses
tumor growth and invasion by targeting KRAS in nasopharyngeal
carcinoma. J Cell Sci. 124:2997–3005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Deng M, Liu JF, Gu YX, Zheng GP and He ZM:
miR-216b suppresses cell proliferation and invasion by targeting
PKCα in nasopharyngeal carcinoma cells. Zhonghua Zhong Liu Za Zhi.
35:645–650. 2013.(In Chinese). PubMed/NCBI
|
|
34
|
Lock FE, Ryan KR, Poulter NS, Parsons M
and Hotchin NA: Differential regulation of adhesion complex
turnover by ROCK1 and ROCK2. PLoS One. 7:e314232012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou X, Wei M and Wang W: MicroRNA-340
suppresses osteosarcoma tumor growth and metastasis by directly
targeting ROCK1. Biochem Biophys Res Commun. 437:653–658. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kaneko K, Satoh K, Masamune A, Satoh A and
Shimosegawa T: Expression of ROCK-1 in human pancreatic cancer: Its
down-regulation by morpholino oligo antisense can reduce the
migration of pancreatic cancer cells in vitro. Pancreas.
24:251–257. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ding W, Tan H, Zhao C, Li X, Li Z, Jiang
C, Zhang Y and Wang L: MiR-145 suppresses cell proliferation and
motility by inhibiting ROCK1 in hepatocellular carcinoma. Tumour
Biol. 37:6255–6260. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cai SD, Chen JS, Xi ZW, Zhang LJ, Niu ML
and Gao ZY: MicroRNA-144 inhibits migration and proliferation in
rectal cancer by downregulating ROCK1. Mol Med Rep. 12:7396–7402.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Huang J, Shi Y, Li H, Yang M and Liu G:
MicroRNA-144 acts as a tumor suppressor by targeting Rho-associated
coiled-coil containing protein kinase 1 in osteosarcoma cells. Mol
Med Rep. 12:4554–4559. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hu CB, Li QL, Hu JF, Zhang Q, Xie JP and
Deng L: miR-124 inhibits growth and invasion of gastric cancer by
targeting ROCK1. Asian Pac J Cancer Prev. 15:6543–6546. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kroiss A, Vincent S, Decaussin-Petrucci M,
Meugnier E, Viallet J, Ruffion A, Chalmel F, Samarut J and Allioli
N: Androgen-regulated microRNA-135a decreases prostate cancer cell
migration and invasion through downregulating ROCK1 and ROCK2.
Oncogene. 34:2846–2855. 2015. View Article : Google Scholar : PubMed/NCBI
|
